OMX Stockholm PI
989,04
|
-20,80
|
-2,06%
|
Analysen zu OMX Stockholm PI-Werten
06:59 | AstraZeneca Buy | UBS AG | |
10.03.25 | AstraZeneca Buy | UBS AG | |
10.03.25 | AstraZeneca Buy | UBS AG | |
07.03.25 | Hennes & Mauritz AB Neutral | UBS AG | |
04.03.25 | AstraZeneca Outperform | Bernstein Research | |
03.03.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
28.02.25 | Volvo AB Buy | Deutsche Bank AG | |
27.02.25 | ABB Hold | Jefferies & Company Inc. | |
26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
26.02.25 | Volvo AB Buy | UBS AG | |
25.02.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
24.02.25 | ABB Neutral | UBS AG | |
24.02.25 | ABB Sector Perform | RBC Capital Markets | |
24.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
24.02.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
20.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
20.02.25 | AstraZeneca Outperform | Bernstein Research | |
20.02.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
18.02.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
13.02.25 | AstraZeneca Buy | UBS AG | |
12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
11.02.25 | ABB Underperform | Bernstein Research | |
11.02.25 | AstraZeneca Outperform | Bernstein Research | |
11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
10.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
07.02.25 | AstraZeneca Halten | DZ BANK | |
07.02.25 | ABB Kaufen | DZ BANK | |
07.02.25 | Volvo AB Sector Perform | RBC Capital Markets | |
07.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
06.02.25 | AstraZeneca Neutral | UBS AG | |
06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.02.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.02.25 | Hennes & Mauritz AB Underperform | Bernstein Research |